Key points are not available for this paper at this time.
This Viewpoint advocates for proactively addressing concerns related to the diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD) in US adults to balance individual benefits with population-level risk.
Blanco et al. (Wed,) studied this question.